MedTrace Logo

National, Multicentric Registry Study on Neuroimmunological Diseases in China

NCT06443333 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 7000

Last updated 2024-06-05

No results posted yet for this study

Summary

The aim of this study is to establish a real-world clinical neuroimmune disease research cohort, to follow up and observe the prognosis of patients with different subtypes and subgroups, and to provide support for the treatment, early warning, and outcome prediction research of neuroimmune diseases.

Conditions

  • Multiple Sclerosis
  • NMO Spectrum Disorder
  • Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
  • Myasthenia Gravis
  • Autoimmune Encephalitis
  • Acute Disseminated Encephalomyelitis

Interventions

OTHER

Data collection and follow-up observation

At the time of enrollment, the patient's biological samples are collected to obtain genetic information. Following enrollment, trained investigators carry out a 2-year follow-up observation through face-to-face, telephone call or online visits. During the follow-up, basic clinical information, laboratory tests, imaging examinations, neurophysiology, clinical classification, medication use, and scale assessments are collected.

OTHER

Data collection

Collect demographic and genetic information from healthy volunteers upon enrollment.

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

  • Junwei Hao, MD · Xuanwu Hospital, Beijing

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2024-12-30
Completion
2024-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06443333 on ClinicalTrials.gov